Platelets are dominant contributors to hypercoagulability after injury
about
Assessing the Methodology for Calculating Platelet Contribution to Clot Strength (Platelet Component) in Thromboelastometry and ThrombelastographyHypercoagulability following blunt solid abdominal organ injury: when to initiate anticoagulationFibrinogen and platelet contributions to clot formation: implications for trauma resuscitation and thromboprophylaxisA Pilot Study to Evaluate Haemostatic Function, following Shock Wave Lithotripsy (SWL) for the Treatment of Solitary Kidney Stones.Transfusion: -80°C Frozen Blood Products Are Safe and Effective in Military Casualty Care.Laboratory assessment of anti-thrombotic therapy in heart failure, atrial fibrillation and coronary artery disease: insights using thrombelastography and a micro-titre plate assay of thrombogenesis and fibrinolysis.Effects of non-vitamin K antagonist oral anticoagulants on fibrin clot and whole blood clot formation, integrity and thrombolysis in patients with atrial fibrillationLower limb orthopaedic surgery results in changes to coagulation and non-specific inflammatory biomarkers, including selective clinical outcome measures.Postinjury hyperfibrinogenemia compromises efficacy of heparin-based venous thromboembolism prophylaxis.Proteomics of apheresis platelet supernatants during routine storage: Gender-related differences.Systemic inflammatory response syndrome and platelet count ≥250×10(9) are associated with venous thromboembolic disease.Onset of Coagulation Function Recovery Is Delayed in Severely Injured Trauma Patients with Venous Thromboembolism.Thromboelastography may predict risk of grade 2 bleeding in thrombocytopenic patients.Refrigeration and cryopreservation of platelets differentially affect platelet metabolism and function: a comparison with conventional platelet storage conditions.Multiplate and TEG platelet mapping in a population of severely injured trauma patients.Viscoelastic hemostatic fibrinogen assays detect fibrinolysis early.Association of Anti-Factor Xa-Guided Dosing of Enoxaparin With Venous Thromboembolism After Trauma.[Iron deficiency, thrombocytosis and thromboembolism].
P2860
Q26785877-862177CF-EAA1-49B4-B88C-37ECDA4D8B98Q33881007-281ABF41-C832-4C0F-A214-ED46AB6C198BQ34549143-7F1871EC-9EFB-49D5-8C86-638DB24D5F98Q35565940-F2559BDF-4B2F-470B-A33F-35186E43E2F2Q36222342-BFDF7AFD-FF3B-4391-9ADC-64A048B67C78Q37018644-3C1470A1-244A-492D-904D-DEF885364FE8Q37293260-81B5F101-A810-48A6-9B29-F828C0465C36Q37320412-0EFA5552-BC51-40A8-B343-AA53267BEFDDQ37518149-EE13ACF9-A021-4DA6-94BA-840F22F6EE14Q37547754-A03245A4-E43E-45C6-9558-9D83AD2AADD6Q38327718-CADBE090-B8C2-45A4-A94F-255078AD5B19Q38896251-AB78E84E-D072-4966-9638-0719CE573CC6Q40051537-A376A598-35F7-492F-9E30-F4BFB24E191AQ47568244-6BE5B498-2FB4-4952-AE9F-936F1AEE879CQ47672527-C0226A55-4EA6-48B2-92F7-74DF4E516FB6Q49164696-8ABEAE21-4744-42F7-8431-EE9D59212E98Q50085838-BD668888-0DF2-4AED-A552-D56DC968F424Q54434317-A1678559-76D6-40F3-B729-615B9BE3C31B
P2860
Platelets are dominant contributors to hypercoagulability after injury
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Platelets are dominant contributors to hypercoagulability after injury
@en
Platelets are dominant contributors to hypercoagulability after injury.
@nl
type
label
Platelets are dominant contributors to hypercoagulability after injury
@en
Platelets are dominant contributors to hypercoagulability after injury.
@nl
prefLabel
Platelets are dominant contributors to hypercoagulability after injury
@en
Platelets are dominant contributors to hypercoagulability after injury.
@nl
P2093
P2860
P1476
Platelets are dominant contributors to hypercoagulability after injury
@en
P2093
Angela Sauaia
Arsen Ghasabyan
Christopher C Silliman
Eduardo Gonzalez
Ernest E Moore
Max V Wohlauer
Theresa L Chin
P2860
P304
756-62; discussion 762-5
P356
10.1097/TA.0B013E3182826D7E
P577
2013-03-01T00:00:00Z